GrowBLOX Sciences (GBLX) Seeks Preferred Provider
Post# of 118
Posted On: 06/26/2015 4:32:23 PM
GrowBLOX Sciences (GBLX) Seeks Preferred Provider Status in Booming Medical Marijuana Market
The State of Nevada is in high anticipation about its upcoming 2016 general election ballot initiative that proposes legalizing recreational use of marijuana. With Colorado’s $700 million wind-fall last year and trending to break $1 billion in annual revenues by 2016, the medical marijuana (MMJ) market in Nevada could very quickly get a whole lot bigger next year.
Poised and positioned to capitalize on this upcoming opportunity is GrowBLOX Sciences (OTC:GBLX). The company has advanced cultivation technology systems that ensure genetic potential of propagated strains that possess more active ingredients per pound than is achieved with any other cultivation method. On June 15, the company secured a $1.75 million funding commitment from Pacific Leaf Ventures to build out its Medical Marijuana Establishment known as The Cultivation Lab through a deal that includes recognizable cannabis brand names and proprietary cultivation and extraction methods. The 28,000-sq.-ft. warehouse is gearing up to produce over 4000 pounds of high-grade cannabis each year.
Although GrowBLOX Sciences deals strictly in medical cannabis products, the monitoring and control systems that are put in place to ensure quality and safety standards at the Las Vegas facility is quickly drawing attention and could possibly be the mandated standard in Nevada by the time legalization is put in place. See The Cultivation Lab design at the following link: http://www.cultivationlabs.com.
GBLX is on schedule for a 4Q completion of The Cultivation Lab. This facility’s purpose is to produce high profile strains and products that appeal to medically approved patients in the state, as well as patients visiting from neighboring Arizona and California. Nevada is the only state to date that recognizes medical marijuana patient cards issued by other states.
The GBLX product line will be distributed from The Apothecary, an eye catching retail space that combines the trustworthy aesthetics of a clean, minimalistic and clinical-feeling interior, with simplified biometrically driven patient verification. The Apothecary layout has a security foyer for initial patient processing, waiting and consultation rooms as well as retail display area, and secure payment section. See the Las Vegas Apothecary at the following link: https://vimeo.com/129493221.
The company believes that combining The Cultivation Labs and The Apothecary will offer patients the quality assurance and safety that they have a grown to expect from any other therapeutic products purchased in the open market. These big moves in Nevada should distinguish GrowBLOX Sciences further from the other players in the field and help make GBLX a preferred solution provider.
For more information, visit www.gbsciences.com
Please see disclaimer on the QualityStocks website: http://Disclaimer.QualityStocks.com
The State of Nevada is in high anticipation about its upcoming 2016 general election ballot initiative that proposes legalizing recreational use of marijuana. With Colorado’s $700 million wind-fall last year and trending to break $1 billion in annual revenues by 2016, the medical marijuana (MMJ) market in Nevada could very quickly get a whole lot bigger next year.
Poised and positioned to capitalize on this upcoming opportunity is GrowBLOX Sciences (OTC:GBLX). The company has advanced cultivation technology systems that ensure genetic potential of propagated strains that possess more active ingredients per pound than is achieved with any other cultivation method. On June 15, the company secured a $1.75 million funding commitment from Pacific Leaf Ventures to build out its Medical Marijuana Establishment known as The Cultivation Lab through a deal that includes recognizable cannabis brand names and proprietary cultivation and extraction methods. The 28,000-sq.-ft. warehouse is gearing up to produce over 4000 pounds of high-grade cannabis each year.
Although GrowBLOX Sciences deals strictly in medical cannabis products, the monitoring and control systems that are put in place to ensure quality and safety standards at the Las Vegas facility is quickly drawing attention and could possibly be the mandated standard in Nevada by the time legalization is put in place. See The Cultivation Lab design at the following link: http://www.cultivationlabs.com.
GBLX is on schedule for a 4Q completion of The Cultivation Lab. This facility’s purpose is to produce high profile strains and products that appeal to medically approved patients in the state, as well as patients visiting from neighboring Arizona and California. Nevada is the only state to date that recognizes medical marijuana patient cards issued by other states.
The GBLX product line will be distributed from The Apothecary, an eye catching retail space that combines the trustworthy aesthetics of a clean, minimalistic and clinical-feeling interior, with simplified biometrically driven patient verification. The Apothecary layout has a security foyer for initial patient processing, waiting and consultation rooms as well as retail display area, and secure payment section. See the Las Vegas Apothecary at the following link: https://vimeo.com/129493221.
The company believes that combining The Cultivation Labs and The Apothecary will offer patients the quality assurance and safety that they have a grown to expect from any other therapeutic products purchased in the open market. These big moves in Nevada should distinguish GrowBLOX Sciences further from the other players in the field and help make GBLX a preferred solution provider.
For more information, visit www.gbsciences.com
Please see disclaimer on the QualityStocks website: http://Disclaimer.QualityStocks.com
(0)
(0)GB Sciences, Inc. (GBLX) Stock Research Links
Scroll down for more posts ▼